GHDx
Published on GHDx (https://ghdx.healthdata.org)


Brazil - São Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, 2021, Phase 5 (SoroEpi MSP)

General Info

Original or alternative title 
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 5
Provider 
SoroEpi MSP
Tabulations only
Geography 
Brazil (BRA)
São Paulo
Coverage type 
Subnational
Time period covered 
January, 2021 - January, 2021
Data type
Survey
Summary 

SoroEpi MSP is a research project that uses serological tests to estimate the percentage of people infected with the new coronavirus in the municipality of São Paulo, in six consecutive moments.

Keywords 
Blood tests, COVID-19, Disease outbreaks, Ethnicity, Incidence, Infectious diseases, Medical tests, Mortality, Prevalence

Citation

Contributors 
Fleury Group
Brazilian Institute of Public Opinion and Statistics (IBOPE)
SEMEIA Institute (Brazil)
Funders 
Brazilian Institute of Public Opinion and Statistics (IBOPE)
SEMEIA Institute (Brazil)
Suggested citation 
Brazilian Institute of Public Opinion and Statistics (IBOPE), Fleury Group, SEMEIA Institute (Brazil). Brazil - São Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, 2021, Phase 5 (SoroEpi MSP).

Source URL:https://ghdx.healthdata.org/record/brazil-s%C3%A3o-paulo-household-survey-estimate-seroprevalence-sars-cov-2-infection-2021-phase-5